HomeJAGSNPHARM • NSE
add
Jagsonpal Pharmaceuticals Ltd
Previous close
₹219.30
Day range
₹210.11 - ₹221.30
Year range
₹110.00 - ₹328.04
Market cap
14.16B INR
Avg Volume
275.47K
P/E ratio
25.97
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 585.60M | 34.66% |
Operating expense | 304.31M | 30.34% |
Net income | 65.83M | 85.49% |
Net profit margin | 11.24 | 37.75% |
Earnings per share | — | — |
EBITDA | 84.42M | 217.90% |
Effective tax rate | 24.40% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.29B | -12.98% |
Total assets | 2.78B | 28.18% |
Total liabilities | 383.10M | 29.09% |
Total equity | 2.40B | — |
Shares outstanding | 67.17M | — |
Price to book | 6.14 | — |
Return on assets | — | — |
Return on capital | 7.03% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 65.83M | 85.49% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1978
Website
Employees
1,025